.png)
Morari Medical announced today that it was selected as one of six companies to participate in the gBETA MedTech Accelerator Program for startups in medical device, digital healthcare, diagnostics and biotech.
gBETA Medtech is a free, seven-week accelerator that works with medical device, healthcarerelated software, biotech and diagnostics startups. Each gBETA program is capped at six companies and requires no fees and takes no equity. Participants receive intensive and individualized coaching and access to physicians, researchers, successful entrepreneurs, angel investors, venture capitalists and industry experts. The program is designed to help startups gain early customer traction on their product or idea and establish metrics that can make them competitive applicants for full-time, equity-based accelerators or seed investment.
Morari Medical is developing a device-based treatment for premature ejaculation (PE). PE is the most prevalent male sexual dysfunction, estimated to affect up to 30% of men worldwide. With a higher incidence than erectile dysfunction or an enlarged prostate, PE represents a large global market opportunity.
“We are honored to be chosen to participate in the gBETA Medtech Accelerator program and the opportunities it will provide us to refine our business plan and expose Morari Medical to local executives, mentors and investors.” said Jeff Bennett, CEO and Founder of Morari. “Sexual health is an emerging market opportunity yet remains a sensitive topic for many. We are grateful to gBETA, Boston Scientific, Mayo Clinic and the University of Minnesota, to provide Morari Medical a forum to discuss an unmet need in sexual health and how our proposed solution will address the need.”
Medtech gBETA Medtech is sponsored by Boston Scientific with support from Mayo Clinic and the University of Minnesota. gBETA Medtech works exclusively with startups focused on healthcare. This includes: healthcare products for the diagnosing, treating and/or monitoring diseases or medical conditions including devices, software, biological technology, and healthcare services, as well as technology or process innovations that could serve any component of the supply chain.
Medical Morari Medical is an early stage medical device company that is developing the first external device for the treatment of premature ejaculation. Grounded in basic science and clinical study research, the Morari product concept is intended to be a transdermal based product using neuromodulation as a means of inhibiting the nerves of the penis, thereby delaying an ejaculation. Please visit www.morarimedical.com to learn more about Morari Medical and connect on Twitter and Facebook
